ISPR vs SKIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ISPR exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -13.06, indicating negative shareholder equity. The company is experiencing a catastrophic revenue collapse of -51.50% YoY alongside deep operating losses and a negative ROE of -428.57%. With consistent earnings misses and bearish insider activity, the fundamental profile suggests a high risk of insolvency or significant further dilution.
The Beauty Health Company (SKIN) presents a high-risk profile characterized by a stable Piotroski F-Score of 5/9 but severely compromised financial health. While valuation metrics like Price/Sales (0.39) and Forward P/E (8.30) appear attractive, they are overshadowed by an extreme Debt/Equity ratio of 6.20 and negative revenue growth. The stock is in a severe long-term downtrend, losing over 90% of its value over 3 and 5 years, suggesting the market is pricing in significant solvency or growth risks.
Compare Another Pair
Related Comparisons
ISPR vs SKIN: Head-to-Head Comparison
This page compares Ispire Technology Inc. (ISPR) and The Beauty Health Company (SKIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.